Landesklinikum St. Polten

Sankt Pölten 3100

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Studies at this site

• Trial of Dacarbazine With or Without Genasense in Advanced Melanoma — Completed
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed